Support program for lung cancer patients awaiting scan results
Support for Cancer Patients Awaiting News (SCAN Study): Pilot Testing a Stress Management Program
NA · Hackensack Meridian Health · NCT06199570
This study is testing a stress management program for advanced lung cancer patients to see if it helps them feel less anxious while waiting for scan results.
Quick facts
| Phase | NA |
|---|---|
| Study type | Interventional |
| Enrollment | 60 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Hackensack Meridian Health (other) |
| Locations | 1 site (Hackensack, New Jersey) |
| Trial ID | NCT06199570 on ClinicalTrials.gov |
What this trial studies
This behavioral intervention aims to pilot test a stress management program specifically designed for patients with advanced lung cancer who are undergoing routine scans. The study consists of two phases: an Open Trial phase to assess feasibility and gather feedback, followed by a Pilot Randomized Controlled Trial phase to evaluate the intervention's acceptability and preliminary effects on anxiety. The program includes psychoeducation and stress management activities delivered through a web platform, tailored to help patients cope with anxiety while waiting for scan results. The goal is to improve quality of life during a challenging time for these patients.
Who should consider this trial
Good fit: Ideal candidates are adults aged 18 and older with Stage III-IV lung cancer who experience appointment- or scan-related stress.
Not a fit: Patients with severe psychiatric illnesses or those currently enrolled in hospice may not benefit from this study.
Why it matters
Potential benefit: If successful, this program could significantly reduce anxiety and improve the quality of life for lung cancer patients awaiting scan results.
How similar studies have performed: Other studies have shown promise in using stress management interventions for cancer patients, indicating potential success for this approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Adult (ages 18 and older) 2. Comfortable speaking, reading, and writing English without an interpreter 3. Established diagnosis of lung cancer (3a. Open Trial phase only: Stage III-IV lung cancer or extensive stage small cell lung cancer) 4. ECOG (Eastern Cooperative Oncology Group) performance status of 0 to 2 5. Receiving ongoing care from collaborating clinics with regular scans 6. Receiving systemic treatment for lung cancer 7. Endorse appointment- or scan-related stress on 4-item screen (using a modified Distress Thermometer item, a Fear of Progression scale item, an Impact of Events scale item, and an item from our prior study) 8. Willingness to use the study website Exclusion Criteria: 1. Moderate-to-severe cognitive impairment (per dementia diagnosis or cognitive screen) 2. Requires an interpreter for medical visits 3. Severe psychiatric illness (psychiatric hospitalization in the past year, or substance use disorder, bipolar disorder, or psychosis diagnosis) 4. Currently enrolled in hospice 5. Unable to complete study activities per oncology provider's judgment (e.g., due to fatigue)
Where this trial is running
Hackensack, New Jersey
- Amanda Khoudary — Hackensack, New Jersey, United States (RECRUITING)
Study contacts
- Principal investigator: Heather Derry-Vick, PhD — Hackensack Meridian Health
- Study coordinator: Amanda Khoudary, BA
- Email: Amanda.Khoudary@hmh-cdi.org
- Phone: 2018803445
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Lung Cancer, Stress management, Cancer related anxiety, Scan related anxiety, Advanced lung cancer, lung cancer